IL-6, together with transforming growth factor beta (TGF-β), induces the generation of Th17 cells, and Th17 cells and other cells producing IL-17A trigger sporadic CRC in mice and humans [75,76,77]. Here, IL6 is linked to colorectal carcinoma.